What is Enlitic?
Enlitic operates at the intersection of artificial intelligence and radiology, providing high-quality software designed to augment the capabilities of medical professionals. The company focuses on developing sophisticated algorithms that assist radiologists in interpreting complex medical imagery, thereby improving diagnostic accuracy and patient outcomes. By adhering to stringent regulatory and statutory requirements, Enlitic has established itself as a trusted partner for healthcare institutions seeking to integrate automated, data-driven insights into their existing clinical workflows. Its market position is defined by a commitment to clinical excellence and the seamless deployment of machine learning tools within the healthcare ecosystem.
How much funding has Enlitic raised?
Enlitic has raised a total of $36.4M across 4 funding rounds:
Angel/Seed
$2M
Series A
$3M
Series B
$25M
Other Financing Round
$6.4M
Angel/Seed (2014): $2M with participation from Amplify.La Capital II and Data Collective
Series A (2015): $3M, investors not publicly disclosed
Series B (2019): $25M supported by Capitol Health, Thorney Investment Group, Marubeni Corporation, Amplify Partners, Regal Funds Management, and The Jagen Group
Other Financing Round (2025): $6.4M, investors not publicly disclosed
Key Investors in Enlitic
Data Collective
A non-profit organization dedicated to advancing knowledge by supporting technology that helps individuals find, understand, and share critical data.
Amplify Partners
A venture capital firm specializing in early-stage investments for companies pioneering novel applications in machine intelligence and computer science.
Regal Funds Management
A leading Australian alternative investment manager known for its fundamental research capabilities and expertise in long/short investment strategies.
What's next for Enlitic?
With the successful closure of this latest financing round, Enlitic is well-positioned to accelerate its product development roadmap and expand its global footprint. The company is expected to prioritize the enhancement of its core diagnostic platforms, focusing on deeper integration with hospital information systems and the expansion of its regulatory approvals across international markets. As the demand for efficient, AI-powered clinical decision support continues to rise, Enlitic's strategic focus will likely center on scaling its enterprise sales force and fostering partnerships with major healthcare providers to drive widespread adoption of its technology.
See full Enlitic company page
